GTI Energy Limited has announced that it has lodged a Notice of General Meeting (NoM) with the ASX, outlining several matters ...

Gold and silver both shine as trusted stores of wealth, but choosing between them depends on a few factors. Here's 5 things ...

Clever Culture Systems Ltd , a leader in AI microbiology automation, has announced the sale of an APASIndependence instrument to Novo Nordisk in Europe. Clever Culture Systems pro ...

Scalare Partners (ASX: SCP), a company that empowers visionary technology founders to transform their ideas into the great businesses of tomorrow by offering products and services to support founders ...

The offer, worth $2.17 billion, reflects a 42.2 per cent premium on Abacus Storage King’s share price prior to the consortium’s initial approach in early April.

Wildcat chairman Jeff Elliott expressed enthusiasm about Bernal’s addition to the executive leadership team. He cited Bernal’s extensive experience and international contacts as valuable assets for ...

DroneShield has announced a $13 million investment in a new research, development and manufacturing facility. This expansion will triple the size of its current facility and is ai ...

Managing Director Todd Williams says this is a defining moment for the Joaquin Project. He notes that hole JDD017-25 confirms shallow, broad, high-grade oxide mineralisation more than 1km south-east ...

Macquarie Technology Group specialises in providing cloud, cyber security, and data centre services to businesses and government organisations. The investment signals the company’s continued expansion ...

According to AIMS, based on AIMS APAC REIT’s historical performance, this investment is expected to deliver a dividend yield of around 8.06% per annum. AIMS Property Securities Fund confirmed that no ...

Bowen Coking Coal Ltd (ASX: BCB) has announced adjustments to its operations at the Burton Mine Complex in response to ongoing challenges in the global steel and coal markets. Bowen Coking Coal has ...

Immutep (ASX:IMM) CEO Marc Voigt shares promising clinical trial updates across the company’s oncology and autoimmune programs.